Skip to main content
Log in

Career feature

What is hindering the drug development industry from achieving diversity, equity and inclusion in its workforce?

  • Career Feature
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

Establishing accountability by implementing measurable metrics to track and monitor DEI dynamics can ensure that it becomes central to an organization’s strategy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. US Food and Drug Administration. FDA Diversity and Inclusion Strategic Plan, 2018–2021 (2017); https://www.fda.gov/media/107939/download

  2. Fry, R. et al. STEM Jobs See Uneven Progress in Increasing Gender, Racial and Ethnic Diversity. Pew Research Center (1 April 2021); https://www.pewresearch.org/science/2021/04/01/stem-jobs-see-uneven-progress-in-increasing-gender-racial-and-ethnic-diversity/

  3. Women in science, technology, engineering, and mathematics (STEM) (quick take). Catalyst (23 August 2022); https://www.catalyst.org/research/women-in-science-technology-engineering-and-mathematics-stem/

  4. Getz, K. et al. Ther. Innov. Regul. Sci. 56, 777–784 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Anders, G. Who’s vaulting into the C-suite? Trends changed fast in 2022. LinkedIn (1 February 2023); https://www.linkedin.com/pulse/whos-vaulting-c-suite-trends-changed-fast-2022-george-anders/

  6. Shang, Z. et al. Can. Med. Assoc. J. 9, E998–E1004 (2021).

    Google Scholar 

  7. Sue, D. W. et al. Am. Psychol. 62, 271–286 (2007).

    Article  PubMed  Google Scholar 

  8. Kim, J. Y. & Meister, A. J. Bus. Ethics https://doi.org/10.1007/s10551-022-05203-0 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  9. Kim, J. Y. & Shang, Z. J. Manage. Stud. https://doi.org/10.1111/joms.12898 (2022).

    Article  Google Scholar 

  10. Kim, J. Y. & Botto, E. The impact of gender microaggressions on team performance in drug development. Applied Clinical Trials (19 May 2022); https://www.appliedclinicaltrialsonline.com/view/the-impact-of-gender-microaggressions-on-team-performance-in-drug-development

  11. Kim, J. Y. & Botto, E. Examining the impact of exclusionary behaviors on team dynamics. Applied Clinical Trials (24 March 2023); https://www.appliedclinicaltrialsonline.com/view/examining-the-impact-of-exclusionary-behaviors-on-team-dynamics

  12. Carr, E. W. et al. The value of belonging at work. Harvard Bus. Rev. (16 December 2019); https://hbr.org/2019/12/the-value-of-belonging-at-work

  13. Chang, E. H. et al. Proc. Natl Acad. Sci. USA 116, 7778–7783 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Kim, J. Y. & Roberson, L. Consult. Psychol. J. 74, 19–39 (2022).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jennifer Y. Kim.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, J.Y., Botto, E. What is hindering the drug development industry from achieving diversity, equity and inclusion in its workforce?. Nat Biotechnol 41, 878–879 (2023). https://doi.org/10.1038/s41587-023-01817-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41587-023-01817-5

  • Springer Nature America, Inc.

Navigation